| 1 |
Douglas Ivan Jennings |
Sanofi-Aventis |
3 |
| 1 |
Douglas Jennings |
Sanofi-Aventis |
3 |
| 3 |
Brian Rowatt |
Sun Chemical |
2 |
| #4 |
Katie Ellard |
Ark Therapeutics |
1 |
| #4 |
Stuart Parsons |
Rtc Industries |
1 |
| #4 |
Colin Richard Mills |
Bae Systems Plc |
1 |
| #4 |
David W. Needham |
Delphi International Operations Luxembourg S.A.R.L. |
1 |
| #4 |
Philip Alan Skone |
Glaxo Group Limited |
1 |
| #4 |
Kevin Warbrick |
Nortel Networks Limited |
1 |
| #4 |
Peter Saunderson |
3Com Technologies |
1 |
| #4 |
William James Templeton-Steadman |
Zi Corporation Of Canada |
1 |
| #4 |
Peter Stephen May |
Koniniklijke Philips N.V. |
1 |
| #4 |
Christopher Benjamin Wakely |
Paradigm Services Limited |
1 |
| #4 |
Kathy Sutton |
Grünenthal Gmbh |
1 |
| #4 |
Wayne C. A. Wright |
Petrotechnik Limited |
1 |
| #4 |
Edward John Thompson |
AT&T |
1 |
| #4 |
Samuel Harrison Hutton |
Glasswall (Ip) Limited |
1 |
| #4 |
Stephen Neidle |
Cancer Research Technology Limited |
1 |
| #4 |
Peter Dearman |
Highview Enterprises Limited |
1 |
| #4 |
Sally Oxenford |
Genentech |
1 |
| #4 |
Michael Peter Golding |
Xerox |
1 |